Specific activity (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Specific activity" in English language version.

refsWebsite

Global rank English rank

7doi.org

2^nd place

6worldcat.org

5^th place

5nih.gov

4^th place

3semanticscholar.org

11^th place

8^th place

2harvard.edu

18^th place

17^th place

1bipm.org

641^st place

955^th place

1lu.se

4,012^th place

4,295^th place

1nist.gov

355^th place

454^th place

1psu.edu

207^th place

136^th place

bipm.org

"SI units for ionizing radiation: becquerel". Resolutions of the 15th CGPM (Resolution 8). 1975. Retrieved 3 July 2015.

doi.org

Breeman, Wouter A. P.; Jong, Marion; Visser, Theo J.; Erion, Jack L.; Krenning, Eric P. (2003). "Optimising conditions for radiolabelling of DOTA-peptides with ⁹⁰Y, ¹¹¹In and ¹⁷⁷Lu at high specific activities". European Journal of Nuclear Medicine and Molecular Imaging. 30 (6): 917–920. doi:10.1007/s00259-003-1142-0. ISSN 1619-7070. PMID 12677301. S2CID 9652140.
de Goeij, J. J. M.; Bonardi, M. L. (2005). "How do we define the concepts specific activity, radioactive concentration, carrier, carrier-free and no-carrier-added?". Journal of Radioanalytical and Nuclear Chemistry. 263 (1): 13–18. doi:10.1007/s10967-005-0004-6. ISSN 0236-5731. S2CID 97433328.
Wessels, Barry W. (1984). "Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies". Medical Physics. 11 (5): 638–645. Bibcode:1984MedPh..11..638W. doi:10.1118/1.595559. ISSN 0094-2405. PMID 6503879.
I. Weeks; I. Beheshti; F. McCapra; A. K. Campbell; J. S. Woodhead (August 1983). "Acridinium esters as high-specific-activity labels in immunoassay". Clinical Chemistry. 29 (8): 1474–1479. doi:10.1093/clinchem/29.8.1474. PMID 6191885.
Neves, M.; Kling, A.; Lambrecht, R. M. (2002). "Radionuclide production for therapeutic radiopharmaceuticals". Applied Radiation and Isotopes. 57 (5): 657–664. CiteSeerX 10.1.1.503.4385. doi:10.1016/S0969-8043(02)00180-X. ISSN 0969-8043. PMID 12433039.
Mausner, Leonard F. (1993). "Selection of radionuclides for radioimmunotherapy". Medical Physics. 20 (2): 503–509. Bibcode:1993MedPh..20..503M. doi:10.1118/1.597045. ISSN 0094-2405. PMID 8492758.
Murray, A. S.; Marten, R.; Johnston, A.; Martin, P. (1987). "Analysis for naturally occuring [sic] radionuclides at environmental concentrations by gamma spectrometry". Journal of Radioanalytical and Nuclear Chemistry. 115 (2): 263–288. doi:10.1007/BF02037443. ISSN 0236-5731. S2CID 94361207.

harvard.edu

ui.adsabs.harvard.edu

Wessels, Barry W. (1984). "Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies". Medical Physics. 11 (5): 638–645. Bibcode:1984MedPh..11..638W. doi:10.1118/1.595559. ISSN 0094-2405. PMID 6503879.
Mausner, Leonard F. (1993). "Selection of radionuclides for radioimmunotherapy". Medical Physics. 20 (2): 503–509. Bibcode:1993MedPh..20..503M. doi:10.1118/1.597045. ISSN 0094-2405. PMID 8492758.

lu.se

nucleardata.nuclear.lu.se

"Table of Isotopes decay data". Lund University. 1990-06-01. Retrieved 2014-01-12.

nih.gov

pubmed.ncbi.nlm.nih.gov

Breeman, Wouter A. P.; Jong, Marion; Visser, Theo J.; Erion, Jack L.; Krenning, Eric P. (2003). "Optimising conditions for radiolabelling of DOTA-peptides with ⁹⁰Y, ¹¹¹In and ¹⁷⁷Lu at high specific activities". European Journal of Nuclear Medicine and Molecular Imaging. 30 (6): 917–920. doi:10.1007/s00259-003-1142-0. ISSN 1619-7070. PMID 12677301. S2CID 9652140.
Wessels, Barry W. (1984). "Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies". Medical Physics. 11 (5): 638–645. Bibcode:1984MedPh..11..638W. doi:10.1118/1.595559. ISSN 0094-2405. PMID 6503879.
I. Weeks; I. Beheshti; F. McCapra; A. K. Campbell; J. S. Woodhead (August 1983). "Acridinium esters as high-specific-activity labels in immunoassay". Clinical Chemistry. 29 (8): 1474–1479. doi:10.1093/clinchem/29.8.1474. PMID 6191885.
Neves, M.; Kling, A.; Lambrecht, R. M. (2002). "Radionuclide production for therapeutic radiopharmaceuticals". Applied Radiation and Isotopes. 57 (5): 657–664. CiteSeerX 10.1.1.503.4385. doi:10.1016/S0969-8043(02)00180-X. ISSN 0969-8043. PMID 12433039.
Mausner, Leonard F. (1993). "Selection of radionuclides for radioimmunotherapy". Medical Physics. 20 (2): 503–509. Bibcode:1993MedPh..20..503M. doi:10.1118/1.597045. ISSN 0094-2405. PMID 8492758.

nist.gov

physics.nist.gov

"Atomic Weights and Isotopic Compositions for All Elements". NIST. Retrieved 2014-01-12.

psu.edu

citeseerx.ist.psu.edu

Neves, M.; Kling, A.; Lambrecht, R. M. (2002). "Radionuclide production for therapeutic radiopharmaceuticals". Applied Radiation and Isotopes. 57 (5): 657–664. CiteSeerX 10.1.1.503.4385. doi:10.1016/S0969-8043(02)00180-X. ISSN 0969-8043. PMID 12433039.

semanticscholar.org

api.semanticscholar.org

Breeman, Wouter A. P.; Jong, Marion; Visser, Theo J.; Erion, Jack L.; Krenning, Eric P. (2003). "Optimising conditions for radiolabelling of DOTA-peptides with ⁹⁰Y, ¹¹¹In and ¹⁷⁷Lu at high specific activities". European Journal of Nuclear Medicine and Molecular Imaging. 30 (6): 917–920. doi:10.1007/s00259-003-1142-0. ISSN 1619-7070. PMID 12677301. S2CID 9652140.
de Goeij, J. J. M.; Bonardi, M. L. (2005). "How do we define the concepts specific activity, radioactive concentration, carrier, carrier-free and no-carrier-added?". Journal of Radioanalytical and Nuclear Chemistry. 263 (1): 13–18. doi:10.1007/s10967-005-0004-6. ISSN 0236-5731. S2CID 97433328.
Murray, A. S.; Marten, R.; Johnston, A.; Martin, P. (1987). "Analysis for naturally occuring [sic] radionuclides at environmental concentrations by gamma spectrometry". Journal of Radioanalytical and Nuclear Chemistry. 115 (2): 263–288. doi:10.1007/BF02037443. ISSN 0236-5731. S2CID 94361207.

worldcat.org

search.worldcat.org

Breeman, Wouter A. P.; Jong, Marion; Visser, Theo J.; Erion, Jack L.; Krenning, Eric P. (2003). "Optimising conditions for radiolabelling of DOTA-peptides with ⁹⁰Y, ¹¹¹In and ¹⁷⁷Lu at high specific activities". European Journal of Nuclear Medicine and Molecular Imaging. 30 (6): 917–920. doi:10.1007/s00259-003-1142-0. ISSN 1619-7070. PMID 12677301. S2CID 9652140.
de Goeij, J. J. M.; Bonardi, M. L. (2005). "How do we define the concepts specific activity, radioactive concentration, carrier, carrier-free and no-carrier-added?". Journal of Radioanalytical and Nuclear Chemistry. 263 (1): 13–18. doi:10.1007/s10967-005-0004-6. ISSN 0236-5731. S2CID 97433328.
Wessels, Barry W. (1984). "Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies". Medical Physics. 11 (5): 638–645. Bibcode:1984MedPh..11..638W. doi:10.1118/1.595559. ISSN 0094-2405. PMID 6503879.
Neves, M.; Kling, A.; Lambrecht, R. M. (2002). "Radionuclide production for therapeutic radiopharmaceuticals". Applied Radiation and Isotopes. 57 (5): 657–664. CiteSeerX 10.1.1.503.4385. doi:10.1016/S0969-8043(02)00180-X. ISSN 0969-8043. PMID 12433039.
Mausner, Leonard F. (1993). "Selection of radionuclides for radioimmunotherapy". Medical Physics. 20 (2): 503–509. Bibcode:1993MedPh..20..503M. doi:10.1118/1.597045. ISSN 0094-2405. PMID 8492758.
Murray, A. S.; Marten, R.; Johnston, A.; Martin, P. (1987). "Analysis for naturally occuring [sic] radionuclides at environmental concentrations by gamma spectrometry". Journal of Radioanalytical and Nuclear Chemistry. 115 (2): 263–288. doi:10.1007/BF02037443. ISSN 0236-5731. S2CID 94361207.